Want to see ES:CBAV full AI Analyst Report?
Total Valuation
Clinica Baviera has a market cap or net worth of €955.38M. The enterprise value is €882.45.
Market Cap€955.38M
Enterprise Value€882.45
Share Statistics
Clinica Baviera has 16,307,580 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,307,580
Owned by Insiders<0.01%
Owned by Institutions―
Financial Efficiency
Clinica Baviera’s return on equity (ROE) is 0.38 and return on invested capital (ROIC) is 29.49%.
Return on Equity (ROE)0.38
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)29.49%
Return on Capital Employed (ROCE)0.44
Revenue Per Employee150.22K
Profits Per Employee21.37K
Employee Count2,009
Asset Turnover1.22
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Clinica Baviera is 21.0. Clinica Baviera’s PEG ratio is 2.92.
PE Ratio21.0
PS Ratio2.74
PB Ratio7.52
Price to Fair Value7.52
Price to FCF17.80
Price to Operating Cash Flow11.90
PEG Ratio2.92
Income Statement
In the last 12 months, Clinica Baviera had revenue of 301.78M and earned 42.06M in profits. Earnings per share was 2.63.
Revenue301.78M
Gross Profit127.08M
Operating Income82.24M
Pretax Income60.11M
Net Income42.06M
EBITDA106.14M
Earnings Per Share (EPS)2.63
Cash Flow
In the last 12 months, operating cash flow was 78.89M and capital expenditures -30.43M, giving a free cash flow of 48.46M billion.
Operating Cash Flow78.89M
Free Cash Flow48.46M
Free Cash Flow per Share2.97
Dividends & Yields
Clinica Baviera pays an annual dividend of €1.568, resulting in a dividend yield of 2.68%
Dividend Per Share€1.568
Dividend Yield2.68%
Payout Ratio88.24%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change31.30%
50-Day Moving Average58.50
200-Day Moving Average52.34
Relative Strength Index (RSI)46.50
Average Volume (3m)2.20K
Important Dates
Clinica Baviera upcoming earnings date is Nov 5, 2026, TBA (Not Confirmed).
Last Earnings DateJul 29, 2026
Next Earnings DateNov 5, 2026
Ex-Dividend Date―
Financial Position
Clinica Baviera as a current ratio of 0.96, with Debt / Equity ratio of 8.87%
Current Ratio0.96
Quick Ratio0.96
Debt to Market Cap<0.01
Net Debt to EBITDA0.60
Interest Coverage Ratio36.05
Taxes
In the past 12 months, Clinica Baviera has paid 17.18M in taxes.
Income Tax17.18M
Effective Tax Rate0.29
Enterprise Valuation
Clinica Baviera EV to EBITDA ratio is 8.39, with an EV/FCF ratio of 19.17.
EV to Sales2.95
EV to EBITDA8.39
EV to Free Cash Flow19.17
EV to Operating Cash Flow11.65
Balance Sheet
Clinica Baviera has €51.59M in cash and marketable securities with €9.90M in debt, giving a net cash position of €41.70M billion.
Cash & Marketable Securities€51.59M
Total Debt€9.90M
Net Cash€41.70M
Net Cash Per Share€2.56
Tangible Book Value Per Share€4.26
Margins
Gross margin is 82.14%, with operating margin of 27.25%, and net profit margin of 13.94%.
Gross Margin82.14%
Operating Margin27.25%
Pretax Margin19.92%
Net Profit Margin13.94%
EBITDA Margin35.17%
EBIT Margin27.25%
Analyst Forecast
The average price target for Clinica Baviera is €71.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€71.50
Price Target Upside21.19% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast10.89%
EPS Growth Forecast17.12%